BioAtla (BCAB) Other Non Operating Income (2020 - 2026)
BioAtla (BCAB) posted quarterly Other Non Operating Income of $3.0 million for Q1 2026, up 30.0% year-over-year from $2.3 million in Q1 2025, and up 660.3% quarter-over-quarter from -$529000.0 in Q4 2025.
BioAtla (BCAB) Other Non Operating Income (2020 - 2026) Analysis & Trends
BioAtla's Other Non Operating Income history runs 7 years deep, the most recent figure standing at $3.0 million for Q1 2026.
- In Q1 2026, Other Non Operating Income rose 30.0% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $382000.0 (down 92.69% YoY), while the FY2025 annual figure was -$302000.0, down 107.25% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $3.0 million, up from -$529000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $3.0 million in Q1 2026, with the low at -$2.0 million in Q3 2025.
- The 5-year median for Other Non Operating Income is $1.0 million (2022), against an average of $865411.8.
- The sharpest annual moves came in 2023 and 2025: Other Non Operating Income soared 1497.83% in 2023, then plunged 390.79% in 2025.
- BioAtla's Other Non Operating Income stood at $1.0 million in 2022, then surged by 58.41% to $1.6 million in 2023, then slipped by 15.58% to $1.4 million in 2024, then tumbled by 138.9% to -$529000.0 in 2025, then surged by 660.3% to $3.0 million in 2026.
- Business Quant data shows BCAB's Other Non Operating Income at $3.0 million in Q1 2026, -$529000.0 in Q4 2025, and -$2.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | BioAtla | 5.41 Mn | 5.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 225,000.00 |
| Mar 31, 2026 | 2.96 Mn |
| Dec 31, 2025 | -529,000.00 |
| Sep 30, 2025 | -1.99 Mn |
| Jun 30, 2025 | -64,000.00 |
| Mar 31, 2025 | 2.28 Mn |
| Dec 31, 2024 | 1.36 Mn |
| Sep 30, 2024 | 684,000.00 |
| Jun 30, 2024 | 900,000.00 |
| Mar 31, 2024 | 1.22 Mn |
| Dec 31, 2023 | 1.61 Mn |
| Sep 30, 2023 | 1.70 Mn |
| Jun 30, 2023 | 1.45 Mn |
| Mar 31, 2023 | 1.47 Mn |
| Dec 31, 2022 | 1.02 Mn |
| Sep 30, 2022 | 400,000.00 |
| Jun 30, 2022 | 149,000.00 |
| Mar 31, 2022 | 92,000.00 |
| Sep 30, 2021 | 765,000.00 |
| Jun 30, 2021 | 79,000.00 |